Artra Group
6029
Wintest
6721
Business Coach
9562
D. Western Therapeutics Institute
4576
Terra Drone
278A
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||
Cash from operating activities | -156.21%-505.74M | -125.80%-197.39M | 11.24%765.08M | 164.64%687.75M | 546.76%259.89M | 40.18M |
Net profit before non-cash adjustment | 640.24%255.6M | -93.66%34.53M | -4.81%544.66M | 188.75%572.21M | 158.33%198.17M | --76.71M |
Total adjustment of non-cash items | -61.58%167.02M | 132.37%434.76M | 98,572.11%187.1M | 97.91%-190K | -141.56%-9.07M | --21.83M |
-Depreciation and amortization | -4.49%136.05M | -3.92%142.45M | 218.79%148.27M | 11.38%46.51M | 22.44%41.76M | --34.1M |
-Reversal of impairment losses recognized in profit and loss | --0 | 416.42%225.39M | --43.65M | ---- | ---- | ---- |
-Disposal profit | 6.12%68.14M | 3,868.36%64.21M | --1.62M | ---- | ---- | --3.97M |
-Other non-cash items | -1,470.82%-37.16M | 142.16%2.71M | 86.23%-6.43M | 8.13%-46.7M | -212.97%-50.83M | ---16.24M |
Changes in working capital | -39.25%-928.37M | -2,101.02%-666.68M | -71.21%33.32M | 63.48%115.74M | 221.31%70.79M | ---58.36M |
-Change in receivables | -1,279.45%-417.69M | 121.32%35.41M | 23.43%-166.11M | -446.75%-216.93M | 46.55%-39.68M | ---74.23M |
-Change in inventory | 56.24%-373.1M | -536.11%-852.7M | 219.13%195.53M | -1,557.76%-164.13M | 105.00%11.26M | ---225.12M |
-Change in prepaid assets | -172.84%-202.69M | -264.66%-74.29M | 308.03%45.12M | -43.17%-21.69M | 23.98%-15.15M | ---19.93M |
-Change in payables | -123.33%-51.44M | 339.44%220.46M | -119.95%-92.07M | 272.54%461.47M | -40.15%123.87M | --206.96M |
-Change in accrued expense | 487.77%147.35M | -16.32%25.07M | 144.21%29.96M | 2,044.06%12.27M | 91.08%-631K | ---7.07M |
-Provision for loans, leases and other losses | -76.08%-36.25M | -137.15%-20.59M | 95.63%55.42M | 348.69%28.33M | -142.88%-11.39M | --26.57M |
-Changes in other current assets | 13,097.62%5.46M | 99.88%-42K | -310.29%-34.52M | 553.54%16.42M | -92.71%2.51M | --34.47M |
Dividends paid (cash flow from operating activities) | ||||||
Dividends received (cash flow from operating activities) | ||||||
Interest paid (cash flow from operating activities) | -16.63%-14.27M | -18.31%-12.23M | -63.99%-10.34M | 3.18%-6.31M | 15.91%-6.51M | -7.75M |
Interest received (cash flow from operating activities) | -58.40%161K | 24.44%387K | 1,536.84%311K | 58.33%19K | 20.00%12K | 10K |
Tax refund paid | 31.12%-115.93M | 55.44%-168.3M | -306.37%-377.67M | -77.54%-92.94M | -113.71%-52.35M | -24.49M |
Other operating cash inflow (outflow) | -19.92%26.61M | 48.06%33.23M | -71.82%22.44M | 135.73%79.62M | 36.18%33.78M | 24.8M |
Operating cash flow | -76.92%-609.17M | -186.12%-344.31M | -40.16%399.82M | 184.54%668.15M | 616.86%234.81M | --32.76M |
Investing cash flow | ||||||
Net PPE purchase and sale | -6,344.16%-173.8M | 75.51%-2.7M | 1.22%-11.01M | 18.03%-11.15M | 82.38%-13.6M | ---77.18M |
Net intangibles purchase and sale | -1,647.31%-117.38M | 72.22%-6.72M | -207.32%-24.19M | 69.10%-7.87M | 39.68%-25.47M | ---42.23M |
Net business purchase and sale | 90.86%-36.13M | 56.98%-395.16M | ---918.45M | ---- | ---- | ---- |
Net investment product transactions | 139.76%7.95M | -127.96%-19.99M | 1,291.50%71.5M | 7.68%-6M | 83.91%-6.5M | ---40.4M |
Advance cash and loans provided to other parties | 80.00%-20M | -92.31%-100M | ---52M | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | --20M | ---- | --28.4M | ---- | ---- | ---- |
Net changes in other investments | 70.63%-36.95M | -531.79%-125.78M | -3,201.49%-19.91M | 88.15%-603K | 86.42%-5.09M | ---37.45M |
Investing cash flow | 45.21%-356.31M | 29.74%-650.34M | -3,512.59%-925.65M | 49.42%-25.62M | 74.32%-50.66M | ---197.27M |
Financing cash flow | ||||||
Net issuance payments of debt | 183.82%363.47M | -122.97%-433.63M | 712.08%1.89B | -188.82%-308.37M | 84.57%347.19M | --188.11M |
Net common stock issuance | 183.96%12.51M | 44.49%4.41M | -99.79%3.05M | --1.43B | ---- | ---- |
Issuance fees | ---- | ---- | ---- | ---19.49M | ---- | ---- |
Net other fund-raising expenses | 730.43%191K | --23K | ---- | 99.90%-1K | 69.64%-1.05M | ---3.46M |
Financing cash flow | 187.65%376.18M | -122.70%-429.2M | 71.38%1.89B | 218.69%1.1B | 87.46%346.14M | --184.65M |
Net cash flow | ||||||
Beginning cash position | -34.54%2.7B | 49.49%4.12B | 172.54%2.76B | 110.15%1.01B | 4.37%481.41M | --461.27M |
Current changes in cash | 58.61%-589.3M | -204.34%-1.42B | -21.82%1.36B | 229.18%1.75B | 2,533.16%530.29M | --20.14M |
Cash adjustments other than cash changes | 1,202,900.00%24.06M | -300.00%-2K | --1K | ---- | ---- | ---- |
End cash Position | -20.95%2.13B | -34.54%2.7B | 49.49%4.12B | 172.54%2.76B | 110.15%1.01B | --481.41M |
Free cash flow | -154.53%-900.36M | -197.01%-353.73M | -43.83%364.62M | 231.63%649.13M | 325.87%195.74M | ---86.66M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |